Stephen Bloch Sells 2,064 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) Director Stephen Bloch sold 2,064 shares of Liquidia stock in a transaction on Friday, June 5th. The shares were sold at an average price of $64.14, for a total transaction of $132,384.96. Following the completion of the transaction, the director owned 1,785,242 shares in the company, valued at approximately $114,505,421.88. This represents a 0.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Liquidia Trading Up 0.2%

NASDAQ LQDA opened at $64.01 on Wednesday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The firm has a market cap of $5.69 billion, a PE ratio of 457.25 and a beta of 0.58. Liquidia Corporation has a one year low of $11.85 and a one year high of $66.78. The firm’s fifty day moving average is $47.90 and its two-hundred day moving average is $40.11.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. The company had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. Liquidia’s quarterly revenue was up 4187.1% on a year-over-year basis. Analysts expect that Liquidia Corporation will post 2.97 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Seven Fleet Capital Management LP increased its stake in shares of Liquidia by 124.5% during the first quarter. Seven Fleet Capital Management LP now owns 204,876 shares of the company’s stock worth $7,732,000 after acquiring an additional 113,609 shares during the period. Segall Bryant & Hamill LLC acquired a new position in shares of Liquidia during the first quarter worth about $2,111,000. Bank of America Corp DE increased its stake in shares of Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after acquiring an additional 360,372 shares during the period. California State Teachers Retirement System increased its stake in shares of Liquidia by 25.0% during the first quarter. California State Teachers Retirement System now owns 72,438 shares of the company’s stock worth $2,734,000 after acquiring an additional 14,485 shares during the period. Finally, Empowered Funds LLC acquired a new position in shares of Liquidia during the first quarter worth about $3,650,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Key Liquidia News

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia will be added to the S&P SmallCap 600 on June 22. Index inclusion often brings passive fund buying and can improve liquidity, which is a strong positive for the stock. Liquidia Corporation Announces Inclusion in the S&P SmallCap 600 Index
• Positive Sentiment: Market commentary highlighted Liquidia’s recent strength and suggested the shares still look undervalued relative to growth prospects, reinforcing investor optimism. Liquidia Corp (LQDA) Stock Up 3.4% and Still Undervalued — GF Score: 75/100
• Neutral Sentiment: Short-interest data showed no shares reported as short, so this update does not currently appear to add meaningful trading pressure either way.
• Negative Sentiment: Director Stephen Bloch sold 2,064 shares, adding to recent insider sales, including larger disposals by Bloch and Paul B. Manning. While the sales are small relative to their holdings, insider selling can weigh on sentiment because it may be viewed as profit-taking. Stephen Bloch Sells 2,064 Shares of Liquidia (NASDAQ:LQDA) Stock

Wall Street Analysts Forecast Growth

A number of research firms have commented on LQDA. Wall Street Zen upgraded shares of Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 16th. Lifesci Capital upgraded shares of Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Oppenheimer set a $75.00 price objective on shares of Liquidia in a research note on Friday. Finally, Zacks Research raised shares of Liquidia from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Liquidia currently has an average rating of “Moderate Buy” and a consensus price target of $55.63.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).